NVS - Novartis AG - ADR
Close
120.89
0.470 0.389%
Share volume: 902,626
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$120.42
0.47
0.39%
Fundamental analysis
66%
Profitability
69%
Dept financing
38%
Liquidity
61%
Performance
70%
Performance
5 Days
1.97%
1 Month
8.01%
3 Months
20.05%
6 Months
22.78%
1 Year
23.16%
2 Year
62.16%
Key data
Stock price
$120.89
DAY RANGE
$120.05 - $120.92
52 WEEK RANGE
$88.80 - $120.92
52 WEEK CHANGE
$0.25
DIVIDEND
$3.7772
EX-DIVIDEND DATE
03/07/2024
NEXT EARNINGS DATE
10/29/2024
Company detail
CEO: Vasant Narasimhan
Region: US
Website: https://www.novartis.com/
Employees: 101,703
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.novartis.com/
Employees: 101,703
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.
Recent news